S
Seagen
Biotech & Life Sciences · Bothell, United States · Founded 1998 · IPO 2001 Decacorn
Investors
5 investors on Seagen's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where Seagen has talent and traffic
(4 of 761 staff)
team presence
Patent intelligence
$403M patent portfolio · 218 active families
Where Seagen concentrates vs peers
Each axis is a top-10 topic across Seagen and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Seagen's 4 investments and acquisitions.
Every disclosed deal where Seagen appeared as a backer or acquirer, 2015–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Seagen's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Seagen's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Seagen
An AI-synthesized read of the highest-engagement posts about Seagen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Seagen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.